Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year

1 Haxhihamza K, Arsova S, Bajraktarov S, Kalpak G, Stefanovski B, Novotni A, Milutinovic M. Patient Satisfaction with Use of Telemedicine in University Clinic of Psychiatry: Skopje, North Macedonia During COVID-19 Pandemic. Telemed, J E Health. 27(4):464-467, 2021 Search in Google Scholar

2 Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21, 335–337 Search in Google Scholar

3 Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J. et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J. Infect. 81, e16–e25, 2020 Search in Google Scholar

4 Richards, M., Anderson, M., Carter, P., Ebert, B. L. & Mossialos, E. The impact of the COVID-19 pandemic on cancer care. Nat. Cancer. 1:565–567, 2020 Search in Google Scholar

5 Maringe, C., Spicer, J., Morris, M., Purushotham, A., Nolte, E., Sullivan, R. et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis: a national population based modelling study. Lancet Oncol. 21:1023–1034, 2020. Search in Google Scholar

6 Sud, A., Torr, B., Jones, M. E., Broggi, J., Scott, S., Loveday, C., Garrett, A., Gronthoud, F., Nicol, D. L., Jhanji, S., Boyce, S. A., Williams, A., Riboli, E., Muller, D. C., Kipps, E., Larkin, J., Navani, N., Swanton, C., Lyratzopoulos, G., McFerran, E., Lawler, M., Houlston, R. & Turnbull, C. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 21:1034–1044, 2020 Search in Google Scholar

7 UK Lung Cancer Coalition (UKLCC). COVID-19 Matters: A Review of the Impact of COVID-19 on the Lung Cancer Pathway and Opportunities for Innovation Emerging from the Health System Response to the Pandemic COVID-19 (UKLCC, 2020) Search in Google Scholar

8 de Joode K, Dumoulin DW, Engelen V, et al. Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective. Eur J Cancer 136:132-9, 2020 Search in Google Scholar

9 Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov 10:783–91, 2020 Search in Google Scholar

10 Helsper, C. W., Campbell, C., Emery, J., Neal, R. D., Li, L., Rubin, G. et al. Cancer has not gone away: a primary care perspective to support a balanced approach for timely cancer diagnosis during COVID‐19. Eur. J. Cancer Care 29, e13290, 2020 Search in Google Scholar

11 Khan, N., Jones, D., Grice, A., Alderson, S., Bradley, S., Carder, P. et al. A brave new world: the new normal for general practice after the COVID-19 pandemic. BJGP Open 4, bjgpopen20X101103, 2020 Search in Google Scholar

12 British Thoracic Society. COVID-19: information for the respiratory community. https://www.brit-thoracic.org.uk/about-us/covid-19-information-for-therespiratory-community/ (2020). Search in Google Scholar

13 Horn, L., Whisenant, J. G., Torri, V., Huang, L.-C., Trama, A., Paz-Ares, L. G. et al. Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): impact of type of cancer therapy and COVID therapy on survival. Am. Soc. Clin. Oncol. 38, LBA111, 2020 Search in Google Scholar

14 Luo, J., Rizvi, H., Preeshagul, I. R., Egger, J. V., Hoyos, D., Bandlamudi, C. et al. COVID-19 in patients with lung cancer. Ann. Oncol. 31, 1386–1396, 2020 Search in Google Scholar

15 Antonoff, M., Backhus, L., Boffa, D. J., Broderick, S. R., Brown, L. M. et al. COVID-19 guidance for triage of operations for thoracic malignancies: a consensus statement from thoracic surgery outcomes research network. J. Thorac. Cardiovasc. Surg. 160, 601–605, 2020 Search in Google Scholar

16 Guckenberger M, Belka C, Bezjak A, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an ESTRO-ASTRO consensus statement. Radiother Oncol 146:223–9, 2020 Search in Google Scholar

17 Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy 12:269–73, 2020 Search in Google Scholar

18 Calabrò L, Peters S, Soria J-C, et al. Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med 8:542–4, 2020 Search in Google Scholar

19 Bakhribah H, Zeitouni M, Daghistani RA, et al. Implications of COVID-19 pandemic on lung cancer management: a multidisciplinary perspective. Crit Rev Oncol Hematol 156:103120, 2020 Search in Google Scholar

20 Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21:1023–34, 2020 Search in Google Scholar

21 Calles, A., Aparicio, M. I., Alva, M., Bringas, M., Gutierrez, N., Soto, J. et al. Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid. Front. Oncol. 10, 1777, 2020 Search in Google Scholar

22 Thomas Round, Veline L’Esperance, Joanne Bayly et al. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary. British Journal of Cancer 125:629–640, 2021. Search in Google Scholar